Inozyme Pharma

Exceptional science. Breakthrough medicines.

Exceptional science. Breakthrough medicines.

At Inozyme Pharma, we are translating scientific insights into therapeutic breakthroughs to benefit patients and their families.

Our Company

Inozyme Pharma is a biotechnology company developing new medicines to treat rare, debilitating, and life-threatening calcification disorders for which there are no adequate treatment options.

Science

We are focused on developing new treatments for rare and serious disorders resulting from deficient levels of a metabolite called pyrophosphate, or PPi. Low PPi contributes to a broad range of calcification disorders that threaten and limit life.

Starburst iconPatients / HCPs

We believe people living with calcification disorders deserve effective therapies. That’s why we’re working with scientists, physicians, and patients to develop breakthrough treatments for diseases of PPi deficiency, or low PPi.

Learn More

Computer iconCareers

At Inozyme Pharma, we are always looking for talented individuals to join our team. If you thrive in an entrepreneurial environment where you can change people’s lives, we encourage you to review our open positions.

Learn More

Newspaper iconCurrent News

April 10, 2019
Inozyme Pharma Raises $67 Million in Series A2 Financing to Develop Therapies for Rare Mineralization Disorders
Read More
Sign up to receive the latest information about Inozyme Pharma and its research and development programs.

You are now signing up to receive email updates and news from Inozyme Pharma. The emails you will receive are not intended to provide you with healthcare advice. Inozyme Pharma will not and does not provide healthcare advice. By registering for this email service, you understand that you are not disclosing any personal, private health information to Inozyme Pharma.

You must be 18 years of age or older to register. By registering to receive these emails, you certify that you are 18 years of age or older and are granting permission to receive general updates and news from Inozyme Pharma.

By providing your information, you agree to allow Inozyme Pharma and its agents to collect the name and email address provided and to be contacted by Inozyme Pharma and its agents using this information in the future. Furthermore, you are agreeing that Inozyme Pharma and its agents may contact you by email. Inozyme Pharma will not sell, rent, or otherwise distribute your name and email address provided.